Featured Research

from universities, journals, and other organizations

Medicare payments for medical imaging are higher to nonradiologist physicians than to radiologists

Date:
January 4, 2011
Source:
American College of Radiology / American Roentgen Ray Society
Summary:
Researchers have found that Medicare payments for non-invasive medical imaging, including magnetic resonance imaging and computed tomography scans, are now higher to non-radiologists than to radiologists, according to a new study.

Researchers have found that Medicare payments for non-invasive medical imaging, including magnetic resonance imaging (MRI) and computed tomography (CT) scans, are now higher to non-radiologists than to radiologists, according to a study in the January issue of the Journal of the American College of Radiology.

"Radiologists have always been considered the physicians who "control" non-invasive diagnostic imaging (NDI) and are primarily responsible for its growth. Yet non-radiologists have become increasingly aggressive in their performance and interpretation of imaging," said David C. Levin, MD, lead author of the study.

Researchers looked at Medicare Part B files covering all fee-for-service physician payments for 1998 to 2008. They selected all codes for discretionary NDI. "We found that the growth in fee-for-service payments to non-radiologists for NDI was considerably more rapid than the growth for radiologists between 1998 and 2006," said Levin.

In 1998, overall Part B payments to radiologists for discretionary NDI were $2.563 billion, compared with $2.020 billion to non-radiologists. In 2008, non-radiologists received $4.807 billion for discretionary NDI, and radiologists received $4.648 billion.

"Our data reveal the somewhat surprising finding that non-radiologist physicians are now paid more for NDI by Medicare than radiologists. This has come about because of more rapid growth in fee-for-service payments to non-radiologists between 1998 and 2006, followed by steeper losses among radiologists after implementation of the DRA in 2007," he said.

"Because most imaging by non-radiologists is self-referred, whereas radiologists generally do not have the opportunity to self-refer, this should be of interest and concern to policy makers and payers," said Levin.


Story Source:

The above story is based on materials provided by American College of Radiology / American Roentgen Ray Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. David C. Levin, Vijay M. Rao, Laurence Parker, Andrea J. Frangos, Jonathan H. Sunshine. Medicare Payments for Noninvasive Diagnostic Imaging Are Now Higher to Nonradiologist Physicians Than to Radiologists. Journal of the American College of Radiology - January, 2011; 8 (1): 26-32 DOI: 10.1016/j.jacr.2010.06.027

Cite This Page:

American College of Radiology / American Roentgen Ray Society. "Medicare payments for medical imaging are higher to nonradiologist physicians than to radiologists." ScienceDaily. ScienceDaily, 4 January 2011. <www.sciencedaily.com/releases/2011/01/110104064025.htm>.
American College of Radiology / American Roentgen Ray Society. (2011, January 4). Medicare payments for medical imaging are higher to nonradiologist physicians than to radiologists. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/01/110104064025.htm
American College of Radiology / American Roentgen Ray Society. "Medicare payments for medical imaging are higher to nonradiologist physicians than to radiologists." ScienceDaily. www.sciencedaily.com/releases/2011/01/110104064025.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins